Editas Medicine (EDIT) – FDA
-
Editas Medicine (EDIT) and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9
-
Editas Medicine (EDIT) Announces New EDIT-301 Safety and Efficacy Data in 17 Patients
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EDIT Stock Lookup